60 results
Page 3 of 3
6-K
EX-1.1
1snpof4on6 q5qch
21 Sep 20
Current report (foreign)
4:15pm
424B5
qcx755oku2gl t3kmb9
16 Sep 20
Prospectus supplement for primary offering
7:24am
6-K
EX-99.1
9vfqj 72xrug73avizf
11 Sep 20
Current report (foreign)
8:16am
6-K
EX-99.1
1zhwxqrvwhs
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
6-K
EX-99.1
o1r58t85l4
8 Apr 20
Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong Kong, Taiwan and Macau
6:03am
424B2
5zfwt
24 Jan 20
Prospectus for primary offering
7:24am
6-K
EX-1.1
wfpknjibfmtn6ve7d
22 Jan 20
Current report (foreign)
11:58am
424B5
aakhll
21 Jan 20
Prospectus supplement for primary offering
5:31pm
20-F/A
EX-10.15
pdvt2k0e31z
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
14hrjr
26 Jun 19
Annual report (foreign) (amended)
6:07am
424B2
7qtg zrf99uy
6 May 19
Prospectus for primary offering
6:04am
6-K
EX-1.1
2djyfbbys55je65y7a
2 May 19
Current report (foreign)
11:39am
424B5
0vp3opx7
1 May 19
Prospectus supplement for primary offering
5:26pm
424B4
bzewmfkl 5422
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
EX-4.11
xysu4x mazi
30 Apr 18
Annual report (foreign)
9:07am
20-F
5altk
30 Apr 18
Annual report (foreign)
9:07am